Key Takeaways
Ali Health Information Technology’s (00241.HK) stock fell more than 4 percent despite the company posting a 35.2 percent jump in annual net profit and declaring its first-ever dividend.
While the results were broadly in line with expectations, the market reacted to signs of slowing growth in the second half of the fiscal year. "The special dividend came as a positive surprise," BofA Securities said in a research report, though it noted the results were slightly below market forecasts.
For the fiscal year ended March 2026, Ali Health’s revenue grew 12 percent year-over-year to RMB 34.3 billion. Net profit increased to RMB 1.94 billion, while adjusted net profit rose 19.3 percent to RMB 2.33 billion. The board proposed a final dividend of RMB 5.95 cents and a special dividend of RMB 13.52 cents per share.
The negative stock reaction highlights investor concerns about the company's growth trajectory, even as the board expressed confidence through the dividend. Shares in Hong Kong last traded at HKD 4.35, down 4.19 percent on the day.
Despite the market's reaction, major brokerages maintained their positive ratings on the stock, though their price targets show a wide variance.
Citi kept its Buy/High Risk rating, setting a target price of HKD 9. The bank said the first-time dividend demonstrates strong confidence in Ali Health's cash generation and capital return policy. In contrast, BofA Securities maintained its Buy rating but with a lower HKD 6 target price, citing the slightly weaker-than-expected results.
The company also announced that Sheng Mengyue would be appointed as Executive Director and Chief Financial Officer, replacing Tu Yanwu.
The post-earnings stock drop puts pressure on the shares, which are now being watched to see if they can hold key technical levels. Investors will be looking to the company's next earnings report for evidence of a re-acceleration in growth to support the confidence shown by the new dividend policy.
This article is for informational purposes only and does not constitute investment advice.
